Yüklüyor......

Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017

Background: Dual antiplatelet therapy improves patient outcome after acute coronary syndrome (ACS), but prescription differences of P2Y12 inhibitor treatments exist. The aim of the present investigation was to study the long-term utilization and patient outcomes of clopidogrel, prasugrel, and ticagr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Med
Asıl Yazarlar: Rezaei, Safoura Sheikh, Gleiss, Andreas, Reichardt, Berthold, Wolzt, Michael
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7690682/
https://ncbi.nlm.nih.gov/pubmed/33114045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113398
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!